Fermentation Without Oxygen

Victor Manuel Reyes-Umaña and Samuel Atwood set out to grow bacteria without air.

Anaerobic fermentation requires less energy, can use a wider variety of inputs, and produce higher yields.

Izote Biosciences reimagines solutions to the fermentation scale-up problem for the $24B bioprocess technology industry. We enable fermentation scale-up in the absence of oxygen, reducing CAPEX by 50%, OPEX by 36%, and overall raw material consumption. Izote Biosciences improves performance and process robustness compared to current aerobic fermentation processes and empowers users by adapting their existing workflows to our in-house production platforms. Izote Biosciences delivers a cost-effective solution to expeditiously develop and deploy the next generation of biomolecules and bioproducts. Izote Biosciences is at the forefront of the new oxygen-free bio-manufacturing era. We are engineering common production hosts (e.g. E. coli/Bacillus) with the ability to grow anaerobically. So both aerobic and anaerobic bugs will work with this technology. Also, since the metabolism produces some oxygen, manufacturing processes requiring oxygen should not be impacted.

→ Website
→ LinkedIn

izote_tank

COMPANY PROFILE: IZOTE BIOSCIENCES

Reducing inputs and increasing speed to product

Unlock the bioeconomy through step-change improvements to the economics of industrial fermentation

FOUNDERS:
→ Victor Manuel Reyes-Umaña
→ Samuel Atwood


LAST FUNDING STAGE:
preSeed

VECTOR:
Biological Machines

svg-image

2

Team Members

svg-image

350K

Funding to Date

3201810_th1-topaz-enhance-faceai


CO-FOUNDER

Victor Manuel Reyes-Umaña

1591220887762-topaz-enhance-faceai


CO-FOUNDER

Sam Atwood

Delve deeper into the world of Biological Machines through our other inspiring articles or discover why we're also passionate about Human Machine Interaction and Machine to Machine Learning.

DIG DEEPER

Related News & Insights

How can we solve the scale-up dilemma with traditional, aerobic fermentation processes? Is it possible to genetically modify the central metabolism of a cell? …
In a recent interview, we had the pleasure of sitting down with the CEO of InnerPlant, Shely Aronov, while she shared her inspiring vision …
CTO and Co-Founder Ouwei Wang, introduces us to the fascinating world of synthetic biology, where everything from bioplastics to food and high-value enzymes are …
Congratulations to Co-Founders Shannon Hall and Ouwei Wang, along with the entire Pow.Bio team, for closing a $9.5M Series A! Read more about Pow.Bios's …

Bee.